
Louiza Labs
Louiza Labs is a YC Summer 2025 (S25) company. Based in San Francisco, CA, USA. Team of 3.
About Louiza Labs
Summary
Louiza Labs builds an AI-powered intelligence platform that synthesizes real-world patient data for pharmaceutical teams managing post-market drugs. It surfaces the patient-level reasons drugs underperform commercially, specifically lack of effectiveness, poor adherence, and payer resistance, work previously done through manual market research and fragmented data vendors. The company's initial focus is women's health and GLP-1 therapeutics.
Go-to-market
Pharmaceutical commercial and medical affairs teams are the buyers, reached through a sales-led motion targeting post-launch drug portfolios in women's health and GLP-1 categories.
From the Y Combinator listing
AI Powered Patient Insights + Pharmcuetical Intelligence
Synthesizing real-world patient insights into actionable data for post-market pharmaceuticals. We deliver real-world patient insights to pharmaceutical teams that explain the primary reasons drugs fail commercially: lack of effectiveness, poor adherence, and payer resistance. Focusing initially on women's health drugs + GLP-1's.
Facts
- B2B / B2B -> Analytics
- San Francisco, CA, USA
- 3
- Active
- Early
Founders (1)
- Larissa Tyagi
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works